Predicting the influence of homologous recombination repair deficiency genes on glioma heterogeneity and patient prognosis using multi-omics analysis and machine learning
PLOS One · 2025
DOI: 10.1371/journal.pone.0337731 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Xin Wu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery and Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, Suzhou, China. Hauptthemen laut MEDLINE: Glioma, Machine Learning, Brain Neoplasms, Recombinational DNA Repair. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Glioma is the most common malignant tumor of the central nervous system, and homologous recombination deficiency (HRD) may play a crucial role in its progression. Our study aimed to predict the impact of HRD on glioma heterogeneity and patient prognosis from a multi-omics perspective.
Methods
We integrated HRD-related gene expression levels and survival information from The Cancer Genome Atlas (TCGA) and Chinese Glioma Genome Atlas (CGGA) databases. Using a combination of machine learning algorithms, we identified the optimal algorithm and constructed the HRD Index model. After validating the model’s accuracy, we assessed the expression heterogeneity of HRD-related genes in vitro using quantitative polymerase chain reaction (qPCR). Multiple omics analyses, including enrichment analysis, genomics, prediction of immune cell subtype infiltration, and drug sensitivity, were employed to demonstrate the heterogeneity and clinical predictive significance of the HRD Index in glioma.
Results
Through algorithm selection, the LASSO-RSF (Least Absolute Shrinkage and Selection Operator – Random Survival Forest) algorithm identified 7 genes (POLR2F, FANCB, PTEN, PLK3, INO80D, PRMT6, and UNG) to construct the HRD Index. Model validation demonstrated excellent accuracy. qPCR results revealed differential expression of these HRD Index genes among different cell lines. Samples grouped by HRD Index showed potential differences in certain cytokine and receptor pathways, as well as varying gene mutation frequencies between groups. Drug sensitivity analysis indicated that the HRD Index could predict treatment efficacy for specific drugs.
Conclusion
Our HRD Index model based on these seven genes significantly correlated with clinical prognosis in glioma patients and holds promise for guiding clinical management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery and Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, Suzhou, China.
ORCID-Profile: Zhong Wang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wu, X., Li, L., Zhan, Z., Chang, M., Li, J., Chen, Z., & Wang, Z. (2025). Predicting the influence of homologous recombination repair deficiency genes on glioma heterogeneity and patient prognosis using multi-omics analysis and machine learning. PLOS One. https://doi.org/10.1371/journal.pone.0337731
Vancouver
Wu X, Li L, Zhan Z, Chang M, Li J, Chen Z, et al. Predicting the influence of homologous recombination repair deficiency genes on glioma heterogeneity and patient prognosis using multi-omics analysis and machine learning. PLOS One. 2025. doi:10.1371/journal.pone.0337731
BibTeX
@article{Wu2025,
author = {Wu, Xin and Li, Longyuan and Zhan, Zheng and Chang, Mei and Li, Jiaxuan and Chen, Zhouqing and Wang, Zhong},
title = {Predicting the influence of homologous recombination repair deficiency genes on glioma heterogeneity and patient prognosis using multi-omics analysis and machine learning},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0337731}
}
EUVIMED